Results 71 to 80 of about 6,115,227 (208)

Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse

Haematologica, 2005
We report two cases of multiple myeloma relapse and progression following a combination of autologous stem cell transplantation and non-myeloablative allogeneic stem cell transplantation.
D Mattei, N Mordini, R Vigna Taglianti, B Bruno, D Rapezzi, A Gallamini   +5 more
doaj  

The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

Haematologica, 2012
Background The role of allogeneic stem cell transplantation in post-remission management of children with high-risk acute myeloid leukemia remains controversial.
Jan-Henning Klusmann, Dirk Reinhardt, Martin Zimmermann, Bernhard Kremens, Josef Vormoor, Michael Dworzak, Ursula Creutzig, Thomas Klingebiel   +7 more
doaj   +1 more source

Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia [PDF]

, 2006
s Karyotypic evolution is a well-known phenomenon in patients with malignant hernatological disorders during disease progression. We describe a 50-year-old male patient who had originally presented with pancytopenia in October 1992.
Wunderlich, Bettina, Kolb, Hans Jochem, Schmetzer, Helga Maria, Schmid, C., Schmetzer, H.M., Kolb, Hans Jochen, Poleck-Dehlin, Brigitte, Poleck-Dehlin, B., Mittermueller, Johann, Schmid, Christoph, Wunderlich, B., Ledderose, G., Mittermüller, Johann, Schmetzer, Helga, Ledderose, Georg, Duell, T., Mittermüller, J., Kolb, H.-J., Duell, Thomas   +18 more
core   +1 more source

Posttransplantation course after allogeneic stem cell transplantation in a patient with advanced mycosis fungoides—Balancing relapse and rejection

JEADV Clinical Practice
Treatment of advanced cutaneous T‐cell lymphoma (CTCL) can be challenging. To date, the only potentially curative treatment option for advanced CTCL is allogeneic hematopoietic stem cell transplantation.
Inga Hansen‐Abeck, Chiara L. Blomen, Finn Abeck, Leopold Torster, Stefan W. Schneider, Nina Booken   +5 more
doaj   +1 more source

Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021 [PDF]

The Swiss Blood Stem Cell Transplantation and Cellular Therapy Group (SBST) leads a mandatory national registry for all hematopoietic stem cell transplants (HCT) and cellular therapies.
Güngör, Tayfun; https://orcid.org/, Renner, Christoph, Ansari, Marc; https://orcid.org/, Schanz, Urs, Chalandon, Yves; https://orcid.org/, Diepold, Miriam, Nair, Gayathri, Baldomero, Helen; https://orcid.org/, Wannesson, Luciano, Pabst, Thomas; https://orcid.org/, Halter, Jörg P, Passweg, Jakob R; https://orcid.org/, Gerull, Sabine; https://orcid.org/, Diesch-Furlanetto, Tamara, Schneidawind, Dominik, Swiss Blood Stem Cell Transplantation Group (SBST), Stussi, Georg; https://orcid.org/, Duchosal, Michel A, Hitz, Felicitas; https://orcid.org/, Holbro, Andreas, Masouridi-Levrat, Stavroula, Heim, Dominik, Arber, Caroline, Daskalakis, Michael; https://orcid.org/, Novak, Urban, Passweg, J.R., Hitz, F., Chalandon, Yves, Duchosal, M.A., Schneidawind, D., Ansari, M., Novak, U., Renner, C., Hitz, Felicitas, Passweg, Jakob R, Diepold, M., Schanz, U., Gerull, S., Arber, C., Daskalakis, M., Pabst, Thomas, Nair, G., Chalandon, Y., Diesch-Furlanetto, T., Masouridi Levrat, Stavroula, Daskalakis, Michael, Ansari Djaberi, Marc Georges, Heim, D., Halter, J.P., Baldomero, H., Masouridi-Levrat, S., Stussi, Georg, Ansari, Marc, Güngör, T., Wannesson, L., Pabst, T., Stussi, G., Gerull, Sabine, Güngör, Tayfun, Holbro, A., Baldomero, Helen   +60 more
core   +1 more source

Breakdown of thymic tolerance - an etiologic link between acute and chronic graft-versus-host disease [PDF]

, 2014
Allogeneic haematopoietic stem cell transplantation (HSCT) is the standard therapy for many disorders of the haematological system. Its use is limited by the major complication acute graft-versus-host disease (GVHD). Development of acute GVHD predisposes
Dertschnig, Simone
core   +1 more source

Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma: a systematic review and meta-analysis

Hematology
To evaluate whether patients with multiple myeloma (MM) could benefit from tandem autologous hematopoietic stem cell transplantation (auto-HSCT), PubMed, Embase, Web of Science and Cochrane Library databases were systematically searched, and 10 eligible ...
Hongtao Li, Yaxin Zheng, Kehai Gao, Chen Tian   +3 more
doaj   +1 more source

Assessment of Post-transplantation Liver Function Tests in Patients Undergoing Allogeneic Stem Cell Transplantation

, 2020
Objective: Allogeneic hematopoietic stem cell transplantation is a treatment with a considerable rate of complete cure in hematological disorders. Hepatic complications are common causes of morbidity and mortality affecting the survival after stem cell ...
Yildizhan, Esra, KAYNAR, LEYLAGÜL, Kiziltepe, MELİH, Eser, Bulent, ÜNAL, ALİ, ÇETİN, MUSTAFA   +5 more
core   +1 more source

Spatiotemporal evolution of early innate immune responses triggered by neural stem cell grafting [PDF]

, 2012
INTRODUCTION: Transplantation of neural stem cells (NSCs) is increasingly suggested to become part of future therapeutic approaches to improve functional outcome of various central nervous system disorders. However, recently it has become clear that only
Van der Linden, Annemie, Herman Goossens, Annemie Van der Linden, De Vocht, Nathalie, Debbie Le Blon, Hoornaert, Chloé, Kristien Reekmans, Berneman, Zwi, Jasmijn Daans, Reekmans, Kristien, Nathalie De Vocht, Ponsaerts, Peter, Fransen, Erik, Chloé Hoornaert, Hoornaert, Chlo\ue9, Erik Fransen, Praet, Jelle, Le Blon, Debbie, Zwi Berneman, Goossens, Herman, Peter Ponsaerts, Jelle Praet, Daans, Jasmijn   +22 more
core   +1 more source

Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases

BMC Neurology, 2010
Background Allogeneic and autologous haematopoietic stem cell transplantation are established treatment options for haematological malignancies and may possibly be employed to treat a range of genetic and autoimmune diseases.
Voß Martin, Bischof Felix
doaj   +1 more source